$CVM | Interview with CEO, Geert Kersten
12 Jan
2016
Written by Mike Elliott

$CVM | Interview with CEO, Geert Kersten »

In this episode of CEOLIVE.TV we talk to Geert Kersten, CEO of CEL-SCI Corp. (NYSE MKT: CVM) who discusses recent updates on the company's Phase 3 FDA Trials as well as what investors can expect for 2016.

Read more...

Login

Lost your password?